Three-dimensional growth behavior of osteoblasts on biomimetic hydroxylapatite scaffolds.

The authors used rapid prototyping to produce three-dimensional hydroxylapatite scaffolds with controlled, fully interconnected porosity. The purpose of this study was to illuminate the effect of hormones on the osteogenic differentiation and to investigate how osteoblasts colonize the three-dimensional scaffold focusing on the formation of the cellular network. Preosteoblasts were seeded onto scaffolds, were optionally treated with the osteogenic hormones triiodo-L-thyronine (T3) and 1,25-dihydroxyvitamin-D3 (D3), and the expression of osteoblastic marker genes was investigated. Confocal laser scanning microscopy was used to investigate the three-dimensional growth behavior. Culturing cells on scaffolds strongly increased the expression of osteocalcin, osteoprotegerin, Runx2, and receptor activator of NFkB-ligand (RANKL). Treatment with T3 increased the expression of osteocalcin but did not change that of osteoprotegerin and Runx2. Treatment with D3 inhibited the expression of osteocalcin, Runx2, and osteoprotegerin. Both hormones had similar effects in the three-dimensional system as found in two-dimensional cultures although more accentuated, indicating that preosteoblasts behave more naturally on three-dimensional structures. The osteoblasts colonized the three-dimensional squared pores of scaffolds by forming a cellular network with a round central channel keeping it into the depth and depositing collagen fibrils. These results provide insight how osteoblasts colonize a three-dimensional system and underline the importance of this environment in osteoblastic differentiation studies.

[1]  S. Milz,et al.  Hydroxyapatite scaffolds for bone tissue engineering made by 3D printing , 2005, Journal of materials science. Materials in medicine.

[2]  Junzo Tanaka,et al.  The effect of calcium ion concentration on osteoblast viability, proliferation and differentiation in monolayer and 3D culture. , 2005, Biomaterials.

[3]  Paul Roschger,et al.  Towards bone replacement materials from calcium phosphates via rapid prototyping and ceramic gelcasting , 2005 .

[4]  Xing‐dong Zhang,et al.  Proliferation and bone-related gene expression of osteoblasts grown on hydroxyapatite ceramics sintered at different temperature. , 2004, Biomaterials.

[5]  S. Spitzer,et al.  Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) Inversely Regulate OPG Gene Expression in Dependence of the Osteoblastic Phenotype , 2004, Calcified Tissue International.

[6]  P. Ma,et al.  Polymeric Scaffolds for Bone Tissue Engineering , 2004, Annals of Biomedical Engineering.

[7]  M. Baumann,et al.  Hydroxyapatite accelerates differentiation and suppresses growth of MC3T3-E1 osteoblasts. , 2003, Journal of biomedical materials research. Part A.

[8]  Y. Min,et al.  Ex Vivo Expansion of Human Umbilical Cord Blood CD34+ Cells in a Collagen Bead—Containing 3-Dimensional Culture System , 2003, International journal of hematology.

[9]  A. Ellinger,et al.  The expression of matrix metalloproteinase‐13 and osteocalcin in mouse osteoblasts is related to osteoblastic differentiation and is modulated by 1,25‐dihydroxyvitamin D3 and thyroid hormones , 2003, Cell biology international.

[10]  S. Spitzer,et al.  1,25-Dihydroxyvitamin D3 inhibits thyroid hormone-induced osteocalcin expression in mouse osteoblast-like cells via a thyroid hormone response element. , 2003, Journal of molecular endocrinology.

[11]  John A Jansen,et al.  Bone formation by rat bone marrow cells cultured on titanium fiber mesh: effect of in vitro culture time. , 2002, Journal of biomedical materials research.

[12]  A Staines,et al.  Bone adaptation to load: microdamage as a stimulus for bone remodelling , 2002, Journal of anatomy.

[13]  J. Jansen,et al.  Initial interaction of U2OS cells with noncoated and calcium phosphate coated titanium substrates. , 2002, Journal of biomedical materials research.

[14]  Rui L Reis,et al.  New partially degradable and bioactive acrylic bone cements based on starch blends and ceramic fillers. , 2002, Biomaterials.

[15]  K. Klaushofer,et al.  A novel cDNA transcript inversely regulated to osteocalcin in differentiating osteoblast-like cells. , 2002, DNA and cell biology.

[16]  R. Legeros,et al.  Properties of osteoconductive biomaterials: calcium phosphates. , 2002, Clinical orthopaedics and related research.

[17]  Kenneth M. Yamada,et al.  Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.

[18]  T. Ma,et al.  Human cord cell hematopoiesis in three-dimensional nonwoven fibrous matrices: in vitro simulation of the marrow microenvironment. , 2001, Journal of hematotherapy & stem cell research.

[19]  T. Martin,et al.  The Osteoblast-specific Transcription Factor Cbfa1 Contributes to the Expression of Osteoprotegerin, a Potent Inhibitor of Osteoclast Differentiation and Function* , 2000, The Journal of Biological Chemistry.

[20]  K. Hong,et al.  Osteoconduction at porous hydroxyapatite with various pore configurations. , 2000, Biomaterials.

[21]  L. Weiss,et al.  In vitro analysis of biodegradable polymer blend/hydroxyapatite composites for bone tissue engineering. , 1999, Journal of biomedical materials research.

[22]  C. Schwartz,et al.  Biphasic synthetic bone substitute use in orthopaedic and trauma surgery: clinical, radiological and histological results , 1999, Journal of materials science. Materials in medicine.

[23]  M. Bostrom,et al.  Biosynthetic bone grafting. , 1999, Clinical orthopaedics and related research.

[24]  M. Hirose,et al.  Restoration to a quiescent and contractile phenotype from a proliferative phenotype of myofibroblast-like human aortic smooth muscle cells by culture on type IV collagen gels. , 1999, Journal of biochemistry.

[25]  H. Ohgushi,et al.  Osteogenic Phenotype Expression of Allogeneic Rat Marrow Cells in Porous Hydroxyapatite Ceramics , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  K. Klaushofer,et al.  Triiodothyronine, a Regulator of Osteoblastic Differentiation: Depression of Histone H4, Attenuation of c-fos/c-jun, and Induction of Osteocalcin Expression , 1997, Calcified Tissue International.

[27]  Makoto Sato,et al.  Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.

[28]  A. Ellinger,et al.  Effects of triiodothyronine on the morphology of cells and matrix, the localization of alkaline phosphatase, and the frequency of apoptosis in long-term cultures of MC3T3-E1 cells. , 1997, Bone.

[29]  S Tamai,et al.  In vitro bone formation by rat marrow cell culture. , 1996, Journal of biomedical materials research.

[30]  T. Allain,et al.  Thyroid hormones and bone. , 1993, The Journal of endocrinology.

[31]  J. Trouillet,et al.  Osseointegration of macroporous calcium phosphate ceramics having a different chemical composition. , 1993, Biomaterials.

[32]  L. Quarles,et al.  Distinct proliferative and differentiated stages of murine MC3T3‐E1 cells in culture: An in vitro model of osteoblast development , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  B Kerebel,et al.  Transformation of biphasic calcium phosphate ceramics in vivo: ultrastructural and physicochemical characterization. , 1989, Journal of biomedical materials research.

[34]  H. Oonishi,et al.  Comparative bone growth behavior in granules of bioceramic materials of various sizes. , 1999, Journal of biomedical materials research.

[35]  G. Daculsi,et al.  Macroporous biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone ingrowth. , 1998, Biomaterials.